CARERX CORP (CRRX.CA) Stock Fundamental Analysis
TSX:CRRX - Toronto Stock Exchange - CA14173C1059 - Common Stock - Currency: CAD
Taking everything into account, CRRX scores 4 out of 10 in our fundamental rating. CRRX was compared to 18 industry peers in the Consumer Staples Distribution & Retail industry. While CRRX seems to be doing ok healthwise, there are quite some concerns on its profitability. CRRX has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
CRRX had negative earnings in the past year.
CRRX had a positive operating cash flow in the past year.
In the past 5 years CRRX always reported negative net income.
Each year in the past 5 years CRRX had a positive operating cash flow.
1.2 Ratios
The Return On Assets of CRRX (-1.68%) is worse than 72.22% of its industry peers.
CRRX has a Return On Equity of -4.35%. This is in the lower half of the industry: CRRX underperforms 77.78% of its industry peers.
CRRX has a worse Return On Invested Capital (3.50%) than 61.11% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CRRX is significantly below the industry average of 8.14%.
The last Return On Invested Capital (3.50%) for CRRX is above the 3 year average (3.05%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.68% | ||
| ROE | -4.35% | ||
| ROIC | 3.5% |
ROA(3y)-5.78%
ROA(5y)-7.42%
ROE(3y)-21.76%
ROE(5y)-50.97%
ROIC(3y)3.05%
ROIC(5y)N/A
1.3 Margins
With a Operating Margin value of 2.16%, CRRX is not doing good in the industry: 61.11% of the companies in the same industry are doing better.
CRRX's Operating Margin has improved in the last couple of years.
CRRX's Gross Margin of 29.53% is in line compared to the rest of the industry. CRRX outperforms 44.44% of its industry peers.
CRRX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.16% | ||
| PM (TTM) | N/A | ||
| GM | 29.53% |
OM growth 3Y3.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.93%
GM growth 5Y-1.4%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CRRX is destroying value.
The number of shares outstanding for CRRX has been increased compared to 1 year ago.
CRRX has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CRRX has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 0.76, we must say that CRRX is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.76, CRRX is not doing good in the industry: 88.89% of the companies in the same industry are doing better.
The Debt to FCF ratio of CRRX is 3.00, which is a good value as it means it would take CRRX, 3.00 years of fcf income to pay off all of its debts.
CRRX has a better Debt to FCF ratio (3.00) than 100.00% of its industry peers.
A Debt/Equity ratio of 0.86 indicates that CRRX is somewhat dependend on debt financing.
CRRX has a Debt to Equity ratio of 0.86. This is in the better half of the industry: CRRX outperforms 72.22% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.86 | ||
| Debt/FCF | 3 | ||
| Altman-Z | 0.76 |
ROIC/WACC0.31
WACC11.32%
2.3 Liquidity
A Current Ratio of 1.07 indicates that CRRX should not have too much problems paying its short term obligations.
CRRX has a Current ratio of 1.07. This is in the lower half of the industry: CRRX underperforms 72.22% of its industry peers.
A Quick Ratio of 0.76 indicates that CRRX may have some problems paying its short term obligations.
CRRX's Quick ratio of 0.76 is amongst the best of the industry. CRRX outperforms 83.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.07 | ||
| Quick Ratio | 0.76 |
3. Growth
3.1 Past
CRRX shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
Looking at the last year, CRRX shows a decrease in Revenue. The Revenue has decreased by -0.69% in the last year.
Measured over the past years, CRRX shows a very strong growth in Revenue. The Revenue has been growing by 24.10% on average per year.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)-0.69%
Revenue growth 3Y11.77%
Revenue growth 5Y24.1%
Sales Q2Q%-0.2%
3.2 Future
Based on estimates for the next years, CRRX will show a very strong growth in Earnings Per Share. The EPS will grow by 31.92% on average per year.
Based on estimates for the next years, CRRX will show a small growth in Revenue. The Revenue will grow by 2.70% on average per year.
EPS Next Y245.13%
EPS Next 2Y117.2%
EPS Next 3Y31.92%
EPS Next 5YN/A
Revenue Next Year2.34%
Revenue Next 2Y3.87%
Revenue Next 3Y2.7%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for CRRX. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 14.88, the valuation of CRRX can be described as correct.
Based on the Price/Forward Earnings ratio, CRRX is valued a bit cheaper than 66.67% of the companies in the same industry.
CRRX is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.39, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 14.88 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CRRX is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, CRRX is valued a bit cheaper than 61.11% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.46 | ||
| EV/EBITDA | 9.2 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CRRX's earnings are expected to grow with 31.92% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y117.2%
EPS Next 3Y31.92%
5. Dividend
5.1 Amount
CRRX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:CRRX (6/6/2025, 7:00:00 PM)
2.83
-0.02 (-0.7%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)
Earnings (Next)
Inst Owners27.54%
Inst Owner ChangeN/A
Ins Owners10.16%
Ins Owner ChangeN/A
Market Cap177.55M
Analysts80
Price Target3.86 (36.4%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-179.49%
Min EPS beat(2)-258.98%
Max EPS beat(2)-100%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.9%
Min Revenue beat(2)-3.67%
Max Revenue beat(2)-2.13%
Revenue beat(4)0
Avg Revenue beat(4)-1.68%
Min Revenue beat(4)-3.67%
Max Revenue beat(4)-0.38%
Revenue beat(8)0
Avg Revenue beat(8)-2.14%
Revenue beat(12)2
Avg Revenue beat(12)-1.85%
Revenue beat(16)4
Avg Revenue beat(16)-0.87%
PT rev (1m)3.52%
PT rev (3m)11.11%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-42.86%
EPS NY rev (1m)0%
EPS NY rev (3m)-36.32%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.24%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.72%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 14.88 | ||
| P/S | 0.48 | ||
| P/FCF | 6.46 | ||
| P/OCF | 4.92 | ||
| P/B | 2.06 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.2 |
EPS(TTM)-0.06
EYN/A
EPS(NY)0.19
Fwd EY6.72%
FCF(TTM)0.44
FCFY15.49%
OCF(TTM)0.58
OCFY20.32%
SpS5.84
BVpS1.38
TBVpS-0.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.68% | ||
| ROE | -4.35% | ||
| ROCE | 4.87% | ||
| ROIC | 3.5% | ||
| ROICexc | 3.76% | ||
| ROICexgc | 11.55% | ||
| OM | 2.16% | ||
| PM (TTM) | N/A | ||
| GM | 29.53% | ||
| FCFM | 7.5% |
ROA(3y)-5.78%
ROA(5y)-7.42%
ROE(3y)-21.76%
ROE(5y)-50.97%
ROIC(3y)3.05%
ROIC(5y)N/A
ROICexc(3y)3.31%
ROICexc(5y)N/A
ROICexgc(3y)11.1%
ROICexgc(5y)N/A
ROCE(3y)4.24%
ROCE(5y)N/A
ROICexcg growth 3Y15.88%
ROICexcg growth 5YN/A
ROICexc growth 3Y25.67%
ROICexc growth 5YN/A
OM growth 3Y3.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.93%
GM growth 5Y-1.4%
F-Score7
Asset Turnover1.64
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.86 | ||
| Debt/FCF | 3 | ||
| Debt/EBITDA | 2.75 | ||
| Cap/Depr | 44.86% | ||
| Cap/Sales | 2.34% | ||
| Interest Coverage | 1.25 | ||
| Cash Conversion | 133.43% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.07 | ||
| Quick Ratio | 0.76 | ||
| Altman-Z | 0.76 |
F-Score7
WACC11.32%
ROIC/WACC0.31
Cap/Depr(3y)51.22%
Cap/Depr(5y)43.4%
Cap/Sales(3y)2.71%
Cap/Sales(5y)2.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y245.13%
EPS Next 2Y117.2%
EPS Next 3Y31.92%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.69%
Revenue growth 3Y11.77%
Revenue growth 5Y24.1%
Sales Q2Q%-0.2%
Revenue Next Year2.34%
Revenue Next 2Y3.87%
Revenue Next 3Y2.7%
Revenue Next 5YN/A
EBIT growth 1Y-1.33%
EBIT growth 3Y15.72%
EBIT growth 5YN/A
EBIT Next Year370.62%
EBIT Next 3Y66.29%
EBIT Next 5YN/A
FCF growth 1Y69.85%
FCF growth 3Y480.16%
FCF growth 5Y59.88%
OCF growth 1Y26.29%
OCF growth 3Y73.54%
OCF growth 5Y42.97%